Skip to main content
Top
Published in: Osteoporosis International 4/2008

01-04-2008 | Original Article

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)

Authors: C. Cooper, F. Jakob, C. Chinn, E. Martin-Mola, P. Fardellone, S. Adami, N. C. Thalassinos, J. Melo-Gomes, D. Torgerson, A. Gibson, F. Marin

Published in: Osteoporosis International | Issue 4/2008

Login to get access

Abstract

Summary

In this observational study of women with an inadequate clinical outcome to osteoporosis therapy, those with a fracture at baseline were more likely to sustain an incident fracture and have a worse health-related quality of life than those without prior fracture.

Introduction

The Observational Study of Severe Osteoporosis (OSSO) was designed to assess the fracture incidence and health-related quality of life (HRQoL) in women with an inadequate clinical outcome to osteoporosis therapy.

Methods

Post-menopausal women (N = 1,885) with established osteoporosis and an inadequate clinical response to osteoporosis drug therapy defined as: a) a fragility fracture despite therapy for one year (index fracture, N = 988), or b) discontinued drug therapy due to adverse effects and/or non-compliance (N = 897), were assessed during one year for HRQoL using the EQ-5D and the QUALEFFO questionnaires.

Results

One hundred and sixty-six (8.8%) women had a total of 209 incident fractures (1,139 fractures/10,000 women-years). Women with an index fracture were more likely to sustain an incident fracture than those without prior fractures (hazard ratio 1.91; 95% CI: 1.37–2.66; p < 0.001). Co-morbidities or antidepressant use at baseline also increased the risk of incident fracture. Median total EQ-5D Health State Values and QUALEFFO scores were worse in women with an incident fracture regardless of index fracture status. The worst scores were reported in the EQ-5D sub-domains of self-care, usual activities and pain/discomfort.

Conclusions

Women with an inadequate response to osteoporosis therapy had a high rate of incident fracture which had an adverse impact on HRQoL.
Literature
2.
go back to reference Cumming SR, Melton LJ III (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRef Cumming SR, Melton LJ III (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRef
3.
go back to reference Marcus R, Wong M, Heath H et al (2002) Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev 23:1535–1541CrossRef Marcus R, Wong M, Heath H et al (2002) Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev 23:1535–1541CrossRef
4.
go back to reference Black DM, Thompson DE, Bauer DC et al, for the Fit Research Group (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 85:4118–4124PubMedCrossRef Black DM, Thompson DE, Bauer DC et al, for the Fit Research Group (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 85:4118–4124PubMedCrossRef
5.
go back to reference Maricic M, Adachi JD, Sarkar S et al (2002) Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 162:1140–1143PubMedCrossRef Maricic M, Adachi JD, Sarkar S et al (2002) Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 162:1140–1143PubMedCrossRef
6.
go back to reference Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomised control trial. JAMA 282:1344–1352PubMedCrossRef Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomised control trial. JAMA 282:1344–1352PubMedCrossRef
7.
go back to reference Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of the effect of alendronate on risk fracture in women existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541PubMedCrossRef Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of the effect of alendronate on risk fracture in women existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541PubMedCrossRef
8.
go back to reference Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. JAMA 282:637–645PubMedCrossRef Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. JAMA 282:637–645PubMedCrossRef
9.
go back to reference Chesnut CH, Silverman S, Andriano K et al (2000) A randomised trial of nasal spray calcitonin in postmenopusal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. Am J Med 109:267–276PubMedCrossRef Chesnut CH, Silverman S, Andriano K et al (2000) A randomised trial of nasal spray calcitonin in postmenopusal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. Am J Med 109:267–276PubMedCrossRef
10.
go back to reference Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441PubMedCrossRef Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441PubMedCrossRef
11.
go back to reference Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468PubMedCrossRef Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468PubMedCrossRef
12.
go back to reference Ettinger B, Pressman A, Schein J et al (1998) Alendronate use among 812 women: prevalence of gastrointestinal complaints, non-compliance with patient instructions, and discontinuation. J Manag Care Pharm 4:488–492 Ettinger B, Pressman A, Schein J et al (1998) Alendronate use among 812 women: prevalence of gastrointestinal complaints, non-compliance with patient instructions, and discontinuation. J Manag Care Pharm 4:488–492
13.
go back to reference Hamilton B, McCoy K, Taggart H (2003) Tolerability and compliance with risedronate in clinical practice. Osteoporos Int 14:259–262PubMed Hamilton B, McCoy K, Taggart H (2003) Tolerability and compliance with risedronate in clinical practice. Osteoporos Int 14:259–262PubMed
14.
go back to reference Solomon DH, Avorn J, Katz JN et al (2005) Compliance with osteoporosis medications. Arch Inter Med 165:2414–2419CrossRef Solomon DH, Avorn J, Katz JN et al (2005) Compliance with osteoporosis medications. Arch Inter Med 165:2414–2419CrossRef
15.
go back to reference Turbi C, Herrero-Beaumont G, Acebes JC et al (2004) Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, non-randomized, observational study. Clin Ther 26:245–256PubMedCrossRef Turbi C, Herrero-Beaumont G, Acebes JC et al (2004) Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, non-randomized, observational study. Clin Ther 26:245–256PubMedCrossRef
16.
go back to reference Tosteson AN, Grove MR, Hammond CS et al (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216PubMedCrossRef Tosteson AN, Grove MR, Hammond CS et al (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216PubMedCrossRef
17.
go back to reference Badamgarav E, Fitzpatrick LA (2006) A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence. Mayo Clin Proc 81:1009–1012PubMedCrossRef Badamgarav E, Fitzpatrick LA (2006) A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence. Mayo Clin Proc 81:1009–1012PubMedCrossRef
20.
go back to reference Lems WF, Hamdy NAT, Netelenbos JC (2006) Teriparatide: an anabolic drug for the treatment of patients with osteoporosis. Ned Tijdschr Geneeskd 150:132–137PubMed Lems WF, Hamdy NAT, Netelenbos JC (2006) Teriparatide: an anabolic drug for the treatment of patients with osteoporosis. Ned Tijdschr Geneeskd 150:132–137PubMed
21.
go back to reference Jakob F, Marin F, Martin-Mola E et al (2006) Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Q J Med 99:531–543 Jakob F, Marin F, Martin-Mola E et al (2006) Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Q J Med 99:531–543
22.
go back to reference Oleksik A, Lips P, Dawson A et al (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent fractures. J Bone Miner Res 15:1384–1392PubMedCrossRef Oleksik A, Lips P, Dawson A et al (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent fractures. J Bone Miner Res 15:1384–1392PubMedCrossRef
23.
go back to reference Lips P, Cooper C, Agnusdei D et al (1999) Quality of life in patients with vertebral fractures: validation of the quality of life questionnaire of the European Foundation for Osteoporosis (Qualeffo). Osteoporos Int 10:150–160PubMedCrossRef Lips P, Cooper C, Agnusdei D et al (1999) Quality of life in patients with vertebral fractures: validation of the quality of life questionnaire of the European Foundation for Osteoporosis (Qualeffo). Osteoporos Int 10:150–160PubMedCrossRef
24.
go back to reference Oleksik AM, Ewing S, Shen W et al (2004) Impact of incident vertebral fractures on health-related quality of life (HRQoL) in post-menopausal women with prevalent vertebral fractures. Osteoporos Int 16:861–870PubMedCrossRef Oleksik AM, Ewing S, Shen W et al (2004) Impact of incident vertebral fractures on health-related quality of life (HRQoL) in post-menopausal women with prevalent vertebral fractures. Osteoporos Int 16:861–870PubMedCrossRef
25.
go back to reference The EuroQol Group (1990) EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef The EuroQol Group (1990) EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef
26.
go back to reference Marra CA, Woolcott JC, Kopec JA et al (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Sci Med 60:1571–1582CrossRef Marra CA, Woolcott JC, Kopec JA et al (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Sci Med 60:1571–1582CrossRef
27.
go back to reference de Vries M, Ouwendijk R, Kessels AG et al (2005) Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 41:261–268PubMedCrossRef de Vries M, Ouwendijk R, Kessels AG et al (2005) Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 41:261–268PubMedCrossRef
28.
go back to reference Wasserfallen J-B, Halabi G, Saudan P et al (2004) Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19:1594–1599PubMedCrossRef Wasserfallen J-B, Halabi G, Saudan P et al (2004) Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19:1594–1599PubMedCrossRef
29.
go back to reference Hall SE, Criddle RA, Comito TL, Prince RL (1999) A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 9:508–515PubMedCrossRef Hall SE, Criddle RA, Comito TL, Prince RL (1999) A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 9:508–515PubMedCrossRef
30.
go back to reference Fletcher A, Gore S, Jones D et al (1992) Quality of life measures in health care. II. Design, analysis and interpretation. BMJ 305:1145–1148PubMed Fletcher A, Gore S, Jones D et al (1992) Quality of life measures in health care. II. Design, analysis and interpretation. BMJ 305:1145–1148PubMed
31.
go back to reference Lips P, Cooper C, Agnusdei D et al (1997) Quality of life as outcome in the treatment of osteoporosis; the development of a questionnaire for quality of life by the European Foundation for osteoporosis. Osteoporos Int 7:36–38PubMedCrossRef Lips P, Cooper C, Agnusdei D et al (1997) Quality of life as outcome in the treatment of osteoporosis; the development of a questionnaire for quality of life by the European Foundation for osteoporosis. Osteoporos Int 7:36–38PubMedCrossRef
33.
go back to reference Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34:599–604PubMedCrossRef Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34:599–604PubMedCrossRef
34.
go back to reference van Schoor NM, Smit JH, Twisk JWR, Lips P (2005) Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study. Osteoporos Int 16:749–756PubMedCrossRef van Schoor NM, Smit JH, Twisk JWR, Lips P (2005) Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study. Osteoporos Int 16:749–756PubMedCrossRef
35.
go back to reference Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef
36.
go back to reference Lindsay R, Silverman SL, Cooper C et al (2001) Risk of a new vertebral fracture in the year following a fracture. JAMA 285:320–323PubMedCrossRef Lindsay R, Silverman SL, Cooper C et al (2001) Risk of a new vertebral fracture in the year following a fracture. JAMA 285:320–323PubMedCrossRef
37.
go back to reference Marin F, Tynan AJ, Mullarney T (2006) Study description and baseline characteristics of the population in the European Forsteo Observational Study (EFOS). Ann Rheum Dis 65(Suppl II):429 Marin F, Tynan AJ, Mullarney T (2006) Study description and baseline characteristics of the population in the European Forsteo Observational Study (EFOS). Ann Rheum Dis 65(Suppl II):429
38.
go back to reference Lips P, van Schoor NM (2005) Quality of life in patients with osteoporosis. Osteoporos Int 16:447–455PubMedCrossRef Lips P, van Schoor NM (2005) Quality of life in patients with osteoporosis. Osteoporos Int 16:447–455PubMedCrossRef
39.
go back to reference Borgström F, Zethraeus N, Johnell O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637–650PubMedCrossRef Borgström F, Zethraeus N, Johnell O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637–650PubMedCrossRef
40.
go back to reference Adachi JD, Ioannidis G, Olszynski WP et al (2002) The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskeletal disorders 3:11PubMedCrossRef Adachi JD, Ioannidis G, Olszynski WP et al (2002) The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskeletal disorders 3:11PubMedCrossRef
41.
go back to reference Martin AR, Sornay-Rendu E, Chandler JM et al (2002) The impact of osteoporosis on quality-of-life: the OFELY Cohort. Bone 31:2002–2032CrossRef Martin AR, Sornay-Rendu E, Chandler JM et al (2002) The impact of osteoporosis on quality-of-life: the OFELY Cohort. Bone 31:2002–2032CrossRef
42.
go back to reference O’Neill TW, Cockerill W, Matthis C et al (2004) Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int 15:760–765PubMedCrossRef O’Neill TW, Cockerill W, Matthis C et al (2004) Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int 15:760–765PubMedCrossRef
43.
go back to reference Brooks R, Rabin R, de Charro F (2003) The measurement and valuation of health status using EQ-5D: a European perspective. Kluwer Academic Publishers, Dordrecht Brooks R, Rabin R, de Charro F (2003) The measurement and valuation of health status using EQ-5D: a European perspective. Kluwer Academic Publishers, Dordrecht
44.
go back to reference Cockerill W, Lunt M, Siloman AJ et al (2004) Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 15:113–119PubMedCrossRef Cockerill W, Lunt M, Siloman AJ et al (2004) Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 15:113–119PubMedCrossRef
45.
go back to reference Silverman SL, Minshall ME, Shen W et al, on behalf of the Health-Related Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study (2001) The relationship of health related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis. Arthritis Rheum 44:2611–2619PubMedCrossRef Silverman SL, Minshall ME, Shen W et al, on behalf of the Health-Related Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study (2001) The relationship of health related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis. Arthritis Rheum 44:2611–2619PubMedCrossRef
46.
go back to reference Brazier JE, Green C, Kanis JA; Committee of Scientific Advisors International Osteoporosis Foundation (2002) A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int 13:768–776PubMedCrossRef Brazier JE, Green C, Kanis JA; Committee of Scientific Advisors International Osteoporosis Foundation (2002) A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int 13:768–776PubMedCrossRef
47.
go back to reference Honkanen K, Honkanen R, Heikkinen L, Kroger H, Saarikoski S (1999) Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol 150:511–516PubMed Honkanen K, Honkanen R, Heikkinen L, Kroger H, Saarikoski S (1999) Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol 150:511–516PubMed
48.
go back to reference Nevitt MC, Cummings SR, Browner WS et al (1992) The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol 135:490–499PubMed Nevitt MC, Cummings SR, Browner WS et al (1992) The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol 135:490–499PubMed
49.
go back to reference Ismail AA, O’Neill TW, Cockerill W et al (2000) Validity of self-report of fractures: results from a prospective study in men and women across Europe. Osteoporos Int 11:248–254PubMedCrossRef Ismail AA, O’Neill TW, Cockerill W et al (2000) Validity of self-report of fractures: results from a prospective study in men and women across Europe. Osteoporos Int 11:248–254PubMedCrossRef
Metadata
Title
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)
Authors
C. Cooper
F. Jakob
C. Chinn
E. Martin-Mola
P. Fardellone
S. Adami
N. C. Thalassinos
J. Melo-Gomes
D. Torgerson
A. Gibson
F. Marin
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 4/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0488-8

Other articles of this Issue 4/2008

Osteoporosis International 4/2008 Go to the issue